Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tolbutamide 250mg/5ml oral suspension
0601021X0AAAKAK
|
Tolbutamide | Tolbutamide | Endocrine System | No data available |
|
Tolbutamide 500mg/5ml oral suspension
0601021X0AAAJAJ
|
Tolbutamide | Tolbutamide | Endocrine System | No data available |
|
Tolvaptan 45mg tablets and Tolvaptan 15mg tablets
0605020Y0AAACAC
|
Tolvaptan | Tolvaptan | Endocrine System | No data available |
|
Tolvaptan 60mg tablets and Tolvaptan 30mg tablets
0605020Y0AAADAD
|
Tolvaptan | Tolvaptan | Endocrine System | No data available |
|
Tolvaptan 90mg tablets and Tolvaptan 30mg tablets
0605020Y0AAAEAE
|
Tolvaptan | Tolvaptan | Endocrine System | No data available |
|
Tri-iodothyronine 20microgram inj ampoules
0602010M0BGAAAB
|
Tri-iodothyronine | Liothyronine sodium | Endocrine System | No data available |
|
Triamcinolone acetonide 40mg/1ml inj pre-filled syringes
0603020Z0AAAAAA
|
Triamcinolone acetonide (Glucocorticoid) | Triamcinolone acetonide | Endocrine System | No data available |
|
Triamcinolone acetonide 80mg/2ml inj pre-filled syringes
0603020Z0AAABAB
|
Triamcinolone acetonide (Glucocorticoid) | Triamcinolone acetonide | Endocrine System | No data available |
|
Trilostane 120mg capsules
0607030T0AAABAB
|
Trilostane | Trilostane | Endocrine System | No data available |
|
Trilostane 60mg capsules
0607030T0AAAAAA
|
Trilostane | Trilostane | Endocrine System | No data available |
|
Trisequens Forte tablets
0604011J0BBABAB
|
Trisequens | Estradiol and estriol with progestogen | Endocrine System | No data available |
|
TRUEone testing strips
0601060D0CJAAA0
|
TRUEone (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
TRUEplus oral gel
0601040I0BIAAAH
|
TRUEplus | Glucose | Endocrine System | No data available |
|
TRUEresult testing strips
0601060D0CTAAA0
|
TRUEresult (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
TrueTrack System testing strips
0601060D0BXAAA0
|
TrueTrack (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Ultratard 100units/ml suspension for injection 10ml vials
0601012N0BBAAAC
|
Insulin zinc suspension (Crystalline) | Insulin zinc suspension (Crystalline) | Endocrine System | No data available |
|
Urine glucose testing tablets
0601060U0AAABAB
|
Urine testing reagents | Urine testing reagents | Endocrine System | No data available |
|
Urofollitropin 150unit inj ampoules
0605010M0AAADAD
|
Urofollitropin | Urofollitropin | Endocrine System | No data available |
|
Urofollitropin 150unit inj vials
0605010M0AAAFAF
|
Urofollitropin | Urofollitropin | Endocrine System | No data available |
|
Urofollitropin 75unit inj ampoules
0605010M0AAACAC
|
Urofollitropin | Urofollitropin | Endocrine System | No data available |
|
Urofollitropin 75unit inj vials
0605010M0AAAEAE
|
Urofollitropin | Urofollitropin | Endocrine System | No data available |
|
Variquel 1mg inj vials
0605020T0BCAAAA
|
Variquel | Terlipressin | Endocrine System | No data available |
|
Variquel 1mg/5ml solution for injection vials
0605020T0BCABAB
|
Variquel | Terlipressin | Endocrine System | No data available |
|
Velosulin 100units/ml solution for injection 10ml vials
0601011N0BFACAL
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
|
Virormone 100mg/2ml solution for injection ampoules
0604020P0BBACAD
|
Virormone (Parenteral) | Testosterone propionate | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.